BrightEdge Fund Investor
BrightEdge is a Cancer Impact Fund by the American Cancer Society, accelerating the fight for a world without cancer by investing in today’s most promising innovations.
Founded Date:
2018-01-01
Investor Type:
Corporate Venture Capital
Employee Number:
11-50
Investment Stage:
Early Stage Venture
Number Of Exists:
3
Investors Number:
21
Industry:
Finance & Banking
Headquarters:
Atlanta, Georgia, United States
Estimated Revenue:
$9.7 million